Edition:
United States

Lonza Group AG (LONN.S)

LONN.S on Virt-X Level 1

272.20CHF
15 Jun 2018
Change (% chg)

CHF-2.80 (-1.02%)
Prev Close
CHF275.00
Open
CHF275.00
Day's High
CHF275.80
Day's Low
CHF272.20
Volume
404,775
Avg. Vol
358,745
52-wk High
CHF278.40
52-wk Low
CHF203.30

Select another date:

Fri, May 4 2018

UPDATE 1-Lonza confirms targets as gets off to good start

ZURICH, May 4 Swiss drug ingredients maker Lonza confirmed its guidance on Friday and said it had got off to a good start this year.

Lonza confirms targets as Q1 gets off to good start

ZURICH, May 4 Swiss drug ingredients maker Lonza confirmed its guidance on Friday and said it had got off to a good start this year.

Lonza's virus factory shows gene therapy's Texas-sized promise

ZURICH Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution.

FOCUS-Lonza's virus factory shows gene therapy's Texas-sized promise

ZURICH, April 10 Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution.

BRIEF-Lonza To Establish Cell- And Gene-Therapy Centers Of Excellence

* LONZA TO ESTABLISH CELL- AND GENE-THERAPY CENTERS OF EXCELLENCE TO ACCELERATE GROWTH Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: